External Application of Rapamycin-Eluting Film at Anastomotic Sites Inhibits Neointimal Hyperplasia in a Canine Model

Annals of Thoracic Surgery

Volumn 84, Issue 2, 2007, Pages 560-567

  Kawatsu, Satoshi ^a   Oda, Katsuhiko ^a   Saiki, Yoshikatsu ^a   Tabata, Yasuhiko ^b   Tabayashi, Koichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COPOLYMER; CYCLINE; EPSILON CAPROLACTONE; POLYLACTIC ACID; RAPAMYCIN; UNCLASSIFIED DRUG;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; BIODEGRADABILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOG; FEMORAL ARTERY; FEMORAL VEIN; FILM; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STENOSIS; VASCULAR SMOOTH MUSCLE;

ANASTOMOSIS, SURGICAL; ANIMALS; BIOFILMS; DISEASE MODELS, ANIMAL; DOGS; FEMORAL ARTERY; HYPERPLASIA; SIROLIMUS; TUNICA INTIMA; VASCULAR SURGICAL PROCEDURES;

EID: 34447563991     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.02.034     Document Type: Article

References (23)

1. Cameron A., Davis K.B., Green G., and Schaff H.V. Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period. N Engl J Med 334 (1996) 216-219
2. Verma S., Szmitko P.E., Weisel R.D., et al. Should radial arteries be used routinely for coronary artery bypass grafting?. Circulation 110 (2004) e40-e46
3. Muneretto C., Negri A., Manfredi J., et al. Safety and usefulness of composite grafts for total arterial myocardial revascularization: a prospective randomized evaluation. J Thorac Cardiovasc Surg 125 (2003) 826-835
4. Sankaranarayanan M., Chua L.P., Ghista D.N., and Tan Y.S. Computational model of blood flow in the aorto-coronary bypass graft. Biomed Eng Online 4 (2005) 14
5. Leask R.L., Butany J., Johnston K.W., Ethier C.R., and Ojha M. Human saphenous vein coronary artery bypass graft morphology, geometry and hemodynamics. Ann Biomed Eng 33 (2005) 301-309
6. O'Brien Jr. J.E., Shi Y., Fard A., Bauer T., Zalewski A., and Mannion J.D. Wound healing around and within saphenous vein bypass grafts. J Thorac Cardiovasc Surg 114 (1997) 38-45
7. Hosono M., Ueda M., Suehiro S., et al. Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis. J Thorac Cardiovasc Surg 120 (2000) 319-328
8. Indolfi C., Mongiardo A., Curcio A., and Torella D. Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents. Trends Cardiovasc Med 13 (2003) 142-148
9. Andersen H.R., Maeng M., Thorwest M., and Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model. Circulation 93 (1996) 1716-1724
10. Sardella G., Mariani P., D'Alessandro M., et al. Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. Thromb Res 117 (2006) 659-664
11. Funayama H., Ishikawa S.E., Kubo N., Yasu T., Saito M., and Kawakami M. Close association of regional interleukin-6 levels in the infarct-related culprit coronary artery with restenosis in acute myocardial infarction. Circ J 70 (2006) 426-429
12. Maffia P., Grassia G., Di Meglio P., et al. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation 114 (2006) 430-437
13. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76 (1995) 412-417
14. Poon M., Marx S.O., Gallo R., Badimon J.J., Taubman M.B., and Marks A.R. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98 (1996) 2277-2283
15. Suzuki T., Kopia G., Hayashi S., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193
16. Rensing B.J., Vos J., Smits P.C., et al. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 22 (2001) 2125-2130
17. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
18. Shi Y., Pieniek M., Fard A., O'Brien J., Mannion J.D., and Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 93 (1996) 340-348
19. Scott N.A., Cipolla G.D., Ross C.E., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
20. Khurana R., Zhuang Z., Bhardwaj S., et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 110 (2004) 2436-2443
21. Kwon H.M., Sangiorgi G., Ritman E.L., et al. Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol 32 (1998) 2072-2079
22. Schachner T., Zou Y., Oberhuber A., et al. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 77 (2004) 1580-1585
23. Schachner T., Oberhuber A., Zou Y., et al. Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts. Eur J Cardiothorac Surg 27 (2005) 302-306